IMIS

Publications | Institutes | Persons | Datasets | Projects | Maps | Infrastructure
[ report an error in this record ]basket (0): add | show Print this page
Marine-derived pharmaceuticals and future prospects
Jeon, Y-J.; Samarakoon, K.W.; Elvitigala, D. A.S. (2015). Marine-derived pharmaceuticals and future prospects, in: Kim, S.-K. Springer handbook of marine biotechnology. pp. 957-968. https://dx.doi.org/10.1007/978-3-642-53971-8_41
In: Kim, S.-K. (2015). Springer handbook of marine biotechnology. Springer-Verlag Berlin Heidelberg: Berlin. ISBN 978-3-642-53970-1. XLVI, 1512 pp. https://dx.doi.org/10.1007/978-3-642-53971-8, more
Available in  Authors 
Authors  Top 
  • Jeon, Y-J.
  • Samarakoon, K.W.
  • Elvitigala, D. A.S.
Abstract
    Over the last decades, the ocean has been identified as a sustained source for the requirements of human beings. The marine environment has an enormous biodiversity and is a source with huge potential for scientific applications. Among the potentials, the pharmaceutical perspective has been identified as having an important and substantial role for future therapeutic uses. Marine-derived secondary metabolites have become a promising source for the design and development of drugs. Therefore, in this chapter, we describe the recent findings of marine derived-secondary metabolites, including halogenated terpenes, steroids and sterols, and polyphenols, along with their therapeutic potentials. Marine proteins and lipids are also targeted to speculate on their role in human health. Moreover, molecular biology approaches and future trends in pharmaceuticals with a view of current drug developments will also be discussed.
All data in the Integrated Marine Information System (IMIS) is subject to the VLIZ privacy policy Top | Authors